Operator of an outsourced pharmaceutical services platform that partners with drug sponsors to help patients and physicians gain early access to treatments for rare diseases, cancer and other life-threatening or seriously debilitating conditions. The company partners with drug developers to help patients and physicians, enabling its clients to gain early access to treatments for rare diseases and other serious life-threatening illnesses that have no viable treatment options available.
Jakarta Selatan, SingaporePharmaceuticals & BiotechMidsize
We focus on providing treatments and services for patients with neurological, rare metabolic, rare immunological conditions, most of which are genetic conditions.